# Mass Balance Recovery and Metabolic Profile of 14C Debio 1450 Following Single Oral and Intravenous Doses in Healthy Male Subjects

> **NCT02595203** · PHASE1 · COMPLETED · sponsor: **Debiopharm International SA** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [14C-pos 1]-Debio 1450 BES Solution
- **DRUG:** [14C-pos 25]-Debio 1450 BES Solution

## Key facts

- **NCT ID:** NCT02595203
- **Lead sponsor:** Debiopharm International SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2016-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02595203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02595203, "Mass Balance Recovery and Metabolic Profile of 14C Debio 1450 Following Single Oral and Intravenous Doses in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02595203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*